ORAMED PHARMACEUTICALS INC. (ORMP) ROI
- 2023-09-30: ROI -5.47%.
- 2019-08-31: ROI -72.30%.
- 2018-08-31: ROI -28.31%.
Complete source-backed roi history.
- Available history
- 2018-08-31 to 2023-09-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2023-09-30 | -5.47% |
| 2019-08-31 | -72.30% |
| 2018-08-31 | -28.31% |
Annual ROI
| Date | ROI |
|---|---|
| 2019-08-31 | -45.21% |
| 2018-08-31 | -28.31% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |